公开(公告)号：EP3725320A1

公开(公告)日：2020-10-21

申请号：EP18889101.4

申请日：2018-12-12

申请人： Korea Research Institute of Bioscience and Biotechnology

发明人： KIM, Byoung Chan ,  KIM, Kyoung Shim ,  LEE, Chul Ho ,  CHANG, Dong Ho ,  KIM, Yong-Hoon ,  NOH, Jung-Ran ,  CHOI, Dong Hui ,  HWANG, Jung Hwan ,  GO, Jun ,  KIM, Jaehun ,  PARK, Hye-Yeon ,  SEO, Yun-Jung ,  RYU, Young-Kyoung ,  LEE, In-Bok ,  CHOI, Young Keun ,  CHOI, Jung-Hyeon

IPC分类号： A61K35/66 ,  A23L33/135 ,  A23K10/16

摘要： The present invention relates to an Agathobaculum sp. strain having prophylactic or therapeutic effects on autism spectrum disorders, and use thereof. When the intestinal microorganism Agathobaculum sp. strain of the present invention was orally administered to valproic acid (VPA)-induced autism model mice and BTBR autism model mice, the effects of remarkably improving autism spectrum disorders including repetitive behaviors, hyperactivity, social deficiency and cognitive/memory dysfunction of the mice were observed, as compared with a non-treated control. Accordingly, it may be usefully applied to foods, drugs, or feeds for preventing or treating autism spectrum disorders, and thus is very useful in the relevant industries.